[Edaily Reporter Shin Ha-yeon ] Shares of RFTECH CO., LTD(061040)are trading higher on news that the company is set to begin full-scale mass production of next-generation 5G antenna filter units (AFUs) for a major North American telecommunications operator.
According to MP Doctor on the 5th, as of 2:21 p.m., RFTECH CO., LTD is trading at 6,600 won, up 7.14% from the previous trading day. During the session, the stock surged as high as 7,520 won, a 22.1% increase from the previous close. (Photo: RFTECH CO., LTD.) RFTECH CO., LTD announced today that it has begun full-scale mass production of AFUs—which will be installed in next-generation 5G base station systems for major North American telecom operators—through a leading domestic telecommunications equipment manufacturer.
The product incorporates RF filter miniaturization technology developed in-house by RFTECH CO., LTD. The company explained that this product represents a model for which it has proactively secured initial supply volumes, serving as proof of its technological capabilities and stable mass-production competitiveness in the field of 5G base station antennas and filters.
RFTECH CO., LTD’s compact filters are characterized by reduced size and weight compared to existing products, while simultaneously improving assembly efficiency and performance stability. Expectations that the company will benefit from the expansion of 5G coverage and network upgrades in North America are also believed to be reflected in its stock price.
RFTECH CO., LTD. official stated, “The mass production of this next-generation AFU for the North American market is highly significant as it marks the application of our compact RF filter technology in the 5G network equipment of major global telecom operators,” adding, “This will serve as an opportunity to strengthen our position in the global 5G equipment market.”
The slump in the non-investment-grade corporate bond market—which has been centered on BBB-rated bonds this year—is expected to spread to A-rated companies next year. As the burden of issuing corporat…
Amid broader market volatility on Thursday, South Korea’s biopharmaceutical sector lacked a clear directional trend, leaving traditional, profitable pharmaceutical and biotech firms to anchor investor…
A forecast indicates that U.S. production of humanoid robots will reach up to 400,000 units by 2030 and 1.5 million units by 2035. Analysts predict that as the humanoid robot industry moves beyond tec…